

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 7.32893095 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.32230988 |
| 3 | motile cilium assembly (GO:0044458) | 5.02522848 |
| 4 | cilium movement (GO:0003341) | 4.40061833 |
| 5 | tolerance induction (GO:0002507) | 4.18444299 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 3.72364364 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71843896 |
| 8 | epithelial cilium movement (GO:0003351) | 3.58051937 |
| 9 | DNA deamination (GO:0045006) | 3.57966184 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.48211666 |
| 11 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24380804 |
| 12 | positive regulation of tolerance induction (GO:0002645) | 3.21448306 |
| 13 | diterpenoid biosynthetic process (GO:0016102) | 3.18216343 |
| 14 | axoneme assembly (GO:0035082) | 3.14896038 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 3.10008652 |
| 16 | regulation of tolerance induction (GO:0002643) | 3.02037977 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 2.97083498 |
| 18 | viral transcription (GO:0019083) | 2.95708853 |
| 19 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.94467137 |
| 20 | cysteine metabolic process (GO:0006534) | 2.89131031 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87414667 |
| 22 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.86935389 |
| 23 | translational termination (GO:0006415) | 2.85863279 |
| 24 | Golgi transport vesicle coating (GO:0048200) | 2.85535847 |
| 25 | COPI coating of Golgi vesicle (GO:0048205) | 2.85535847 |
| 26 | aldehyde catabolic process (GO:0046185) | 2.81557001 |
| 27 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.80219350 |
| 28 | cytidine deamination (GO:0009972) | 2.77124751 |
| 29 | cytidine metabolic process (GO:0046087) | 2.77124751 |
| 30 | cytidine catabolic process (GO:0006216) | 2.77124751 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 2.76265633 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74224803 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74224803 |
| 34 | reactive oxygen species biosynthetic process (GO:1903409) | 2.72402392 |
| 35 | protein targeting to ER (GO:0045047) | 2.70254953 |
| 36 | ribosomal small subunit biogenesis (GO:0042274) | 2.70020657 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69519616 |
| 38 | cotranslational protein targeting to membrane (GO:0006613) | 2.68992741 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68261470 |
| 40 | response to nitrosative stress (GO:0051409) | 2.67293043 |
| 41 | left/right pattern formation (GO:0060972) | 2.65439302 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 2.64089502 |
| 43 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.63741215 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63442287 |
| 45 | negative regulation of cell killing (GO:0031342) | 2.63442287 |
| 46 | folic acid metabolic process (GO:0046655) | 2.61744868 |
| 47 | translational elongation (GO:0006414) | 2.59454019 |
| 48 | regulation of RIG-I signaling pathway (GO:0039535) | 2.59437791 |
| 49 | cellular response to type I interferon (GO:0071357) | 2.59080840 |
| 50 | type I interferon signaling pathway (GO:0060337) | 2.59080840 |
| 51 | drug transport (GO:0015893) | 2.58685574 |
| 52 | response to type I interferon (GO:0034340) | 2.58630894 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 2.58361462 |
| 54 | GDP-mannose metabolic process (GO:0019673) | 2.58243430 |
| 55 | drug transmembrane transport (GO:0006855) | 2.57125653 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57117219 |
| 57 | lipoxygenase pathway (GO:0019372) | 2.56565508 |
| 58 | response to interferon-beta (GO:0035456) | 2.55731058 |
| 59 | detection of bacterium (GO:0016045) | 2.55352778 |
| 60 | L-phenylalanine metabolic process (GO:0006558) | 2.55249601 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.55249601 |
| 62 | urate metabolic process (GO:0046415) | 2.55016362 |
| 63 | glucuronate metabolic process (GO:0019585) | 2.54287367 |
| 64 | uronic acid metabolic process (GO:0006063) | 2.54287367 |
| 65 | cellular glucuronidation (GO:0052695) | 2.53650753 |
| 66 | ribosomal large subunit biogenesis (GO:0042273) | 2.52287565 |
| 67 | proteasome assembly (GO:0043248) | 2.51894296 |
| 68 | response to xenobiotic stimulus (GO:0009410) | 2.51867243 |
| 69 | proline metabolic process (GO:0006560) | 2.51277066 |
| 70 | homocysteine metabolic process (GO:0050667) | 2.51265896 |
| 71 | flavonoid metabolic process (GO:0009812) | 2.49977306 |
| 72 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.49445695 |
| 73 | maturation of SSU-rRNA (GO:0030490) | 2.48735310 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48068490 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 2.44064903 |
| 76 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.43475438 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.41392587 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.41053438 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.40681232 |
| 80 | regulation of respiratory burst (GO:0060263) | 2.40402998 |
| 81 | hydrogen peroxide catabolic process (GO:0042744) | 2.40145283 |
| 82 | glyoxylate metabolic process (GO:0046487) | 2.39946416 |
| 83 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.39397214 |
| 84 | regulation of germinal center formation (GO:0002634) | 2.39366562 |
| 85 | T cell apoptotic process (GO:0070231) | 2.38765159 |
| 86 | primary alcohol catabolic process (GO:0034310) | 2.38726601 |
| 87 | glutathione derivative biosynthetic process (GO:1901687) | 2.37385543 |
| 88 | glutathione derivative metabolic process (GO:1901685) | 2.37385543 |
| 89 | urea metabolic process (GO:0019627) | 2.36981825 |
| 90 | urea cycle (GO:0000050) | 2.36981825 |
| 91 | response to peptidoglycan (GO:0032494) | 2.36042582 |
| 92 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.35769641 |
| 93 | aromatic amino acid family catabolic process (GO:0009074) | 2.34205118 |
| 94 | indolalkylamine catabolic process (GO:0046218) | 2.34114430 |
| 95 | tryptophan catabolic process (GO:0006569) | 2.34114430 |
| 96 | indole-containing compound catabolic process (GO:0042436) | 2.34114430 |
| 97 | detection of other organism (GO:0098543) | 2.33959964 |
| 98 | vitamin transmembrane transport (GO:0035461) | 2.33754186 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 2.32141794 |
| 100 | negative regulation of stress fiber assembly (GO:0051497) | 2.31957228 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.31761018 |
| 102 | L-phenylalanine catabolic process (GO:0006559) | 2.31493103 |
| 103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.31493103 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.31371670 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.31371670 |
| 106 | cellular response to interferon-beta (GO:0035458) | 2.31267305 |
| 107 | translational initiation (GO:0006413) | 2.30969992 |
| 108 | negative regulation of humoral immune response (GO:0002921) | 2.30750334 |
| 109 | regulation of cilium movement (GO:0003352) | 2.30467178 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.30429458 |
| 111 | leukocyte apoptotic process (GO:0071887) | 2.30335003 |
| 112 | viral life cycle (GO:0019058) | 2.29935720 |
| 113 | bile acid and bile salt transport (GO:0015721) | 2.29536546 |
| 114 | intestinal absorption (GO:0050892) | 2.29372193 |
| 115 | nucleoside salvage (GO:0043174) | 2.29015766 |
| 116 | glutathione biosynthetic process (GO:0006750) | 2.28850453 |
| 117 | xenobiotic catabolic process (GO:0042178) | 2.28826615 |
| 118 | proline biosynthetic process (GO:0006561) | 2.28689302 |
| 119 | glycine metabolic process (GO:0006544) | 2.27328502 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.27020555 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26750191 |
| 122 | B cell mediated immunity (GO:0019724) | 2.26614592 |
| 123 | peptide catabolic process (GO:0043171) | 2.26246316 |
| 124 | nitrogen cycle metabolic process (GO:0071941) | 2.25973707 |
| 125 | pentose metabolic process (GO:0019321) | 2.25799245 |
| 126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.25588691 |
| 127 | hepatocyte apoptotic process (GO:0097284) | 2.25231652 |
| 128 | cellular response to zinc ion (GO:0071294) | 2.25186873 |
| 129 | lymphocyte apoptotic process (GO:0070227) | 2.23007528 |
| 130 | ethanol metabolic process (GO:0006067) | 2.22966374 |
| 131 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.22920552 |
| 132 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.21810488 |
| 133 | autophagic vacuole fusion (GO:0000046) | 2.21058451 |
| 134 | regulation of autophagic vacuole assembly (GO:2000785) | 2.20668435 |
| 135 | serine family amino acid catabolic process (GO:0009071) | 2.20469472 |
| 136 | tryptophan metabolic process (GO:0006568) | 2.19981654 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.19975332 |
| 138 | oxidative phosphorylation (GO:0006119) | 2.19273626 |
| 139 | regulation of gamma-delta T cell activation (GO:0046643) | 2.18630041 |
| 140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.18577190 |
| 141 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.18097844 |
| 142 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.17948424 |
| 143 | formation of translation preinitiation complex (GO:0001731) | 2.16780133 |
| 144 | one-carbon compound transport (GO:0019755) | 2.16142531 |
| 145 | glutathione metabolic process (GO:0006749) | 2.16060013 |
| 146 | positive regulation of interleukin-17 production (GO:0032740) | 2.16039605 |
| 147 | leukocyte aggregation (GO:0070486) | 2.15564894 |
| 148 | translation (GO:0006412) | 2.15136214 |
| 149 | mature B cell differentiation involved in immune response (GO:0002313) | 2.15019063 |
| 150 | regulation of superoxide anion generation (GO:0032928) | 2.14727758 |
| 151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.14568539 |
| 152 | regulation of regulatory T cell differentiation (GO:0045589) | 2.14427241 |
| 153 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.13808991 |
| 154 | amino-acid betaine metabolic process (GO:0006577) | 2.13201451 |
| 155 | protein maturation by protein folding (GO:0022417) | 2.13180728 |
| 156 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.12873527 |
| 157 | signal peptide processing (GO:0006465) | 2.12772960 |
| 158 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.12688324 |
| 159 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.12592941 |
| 160 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.12474671 |
| 161 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.12266813 |
| 162 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.12196407 |
| 163 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.11648663 |
| 164 | cellular protein complex disassembly (GO:0043624) | 2.11597842 |
| 165 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.10968879 |
| 166 | T-helper 1 type immune response (GO:0042088) | 2.10911291 |
| 167 | ethanol oxidation (GO:0006069) | 2.10633175 |
| 168 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.09880913 |
| 169 | hydrogen peroxide metabolic process (GO:0042743) | 2.09736727 |
| 170 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.09398980 |
| 171 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.08863785 |
| 172 | pantothenate metabolic process (GO:0015939) | 2.07885192 |
| 173 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.07494849 |
| 174 | primary alcohol metabolic process (GO:0034308) | 2.07346409 |
| 175 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.07078286 |
| 176 | renal absorption (GO:0070293) | 2.06396317 |
| 177 | organic cation transport (GO:0015695) | 2.05610897 |
| 178 | positive regulation of antigen processing and presentation (GO:0002579) | 2.04504185 |
| 179 | sulfur amino acid metabolic process (GO:0000096) | 2.03705223 |
| 180 | pentose-phosphate shunt (GO:0006098) | 2.03377585 |
| 181 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.02877382 |
| 182 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.02839884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.48218670 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.32788542 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90295640 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.74985686 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64884562 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.57876699 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51670742 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45463841 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.40718636 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35376217 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.29656779 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.29407021 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.10929221 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06607613 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05781087 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93606389 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93164416 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.89581850 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.80345701 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79650851 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77966753 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77509645 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77337570 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76867269 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76750627 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73541793 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71802634 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71790552 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71591963 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70696765 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69327302 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66061637 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.65276339 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63813814 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60186126 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60114430 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58688859 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57183079 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56694883 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56590005 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56503324 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54419309 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53650934 |
| 44 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51381352 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.50371071 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47483276 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46804194 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45264839 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43491850 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42279571 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41280796 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41266334 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38914005 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37879957 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36732753 |
| 56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36467829 |
| 57 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36143705 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.35058495 |
| 59 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.33918414 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.33808384 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33687171 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31308110 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31174840 |
| 64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30150917 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29613761 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29226277 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28747108 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27886722 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27873866 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27681540 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27209456 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26078137 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25720226 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22974630 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22949985 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22270427 |
| 77 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22262766 |
| 78 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22224647 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21684511 |
| 80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19874919 |
| 81 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19163204 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19065800 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18486810 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17889719 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17306320 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17117374 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.17029921 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16289331 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16172794 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15048091 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15027183 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14904731 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14422858 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 1.14226707 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14185698 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14076817 |
| 97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13982897 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13575621 |
| 99 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12591892 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.12177600 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12174678 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12162352 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11699752 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10752080 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10307101 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09974050 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09752727 |
| 108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09582147 |
| 109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09564503 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09415827 |
| 111 | * MYB_26560356_Chip-Seq_TH1_Human | 1.09032629 |
| 112 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08850062 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08351292 |
| 114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08030785 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07555146 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06537225 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05626586 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04794000 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04598976 |
| 120 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04053652 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03830036 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02838792 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02185336 |
| 124 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01237021 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01165683 |
| 126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00614140 |
| 127 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00588176 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99845074 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99773064 |
| 130 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99017574 |
| 131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98504772 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97799593 |
| 133 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96749891 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94285745 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93501425 |
| 136 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92527975 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92242313 |
| 138 | MYC_22102868_ChIP-Seq_BL_Human | 0.91384391 |
| 139 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91227431 |
| 140 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90373654 |
| 141 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89940818 |
| 142 | MYB_26560356_Chip-Seq_TH2_Human | 0.89889329 |
| 143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89560199 |
| 144 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89257628 |
| 145 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88906363 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88267498 |
| 147 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87975105 |
| 148 | MAF_26560356_Chip-Seq_TH1_Human | 0.87624148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.94594691 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.30848802 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.97544501 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.54832094 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.44497150 |
| 6 | MP0003186_abnormal_redox_activity | 2.32540199 |
| 7 | MP0005365_abnormal_bile_salt | 2.25597245 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.23441513 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14955192 |
| 10 | MP0009840_abnormal_foam_cell | 2.06132745 |
| 11 | MP0009785_altered_susceptibility_to | 1.97310428 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 1.96767302 |
| 13 | MP0010155_abnormal_intestine_physiology | 1.87256742 |
| 14 | MP0000685_abnormal_immune_system | 1.85815740 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 1.82861604 |
| 16 | MP0003252_abnormal_bile_duct | 1.81557335 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.81476313 |
| 18 | MP0001873_stomach_inflammation | 1.80013121 |
| 19 | MP0009643_abnormal_urine_homeostasis | 1.77300538 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.75690477 |
| 21 | MP0000490_abnormal_crypts_of | 1.74482050 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.73710586 |
| 23 | MP0003303_peritoneal_inflammation | 1.73534541 |
| 24 | MP0005332_abnormal_amino_acid | 1.72454468 |
| 25 | MP0003436_decreased_susceptibility_to | 1.71841961 |
| 26 | MP0005451_abnormal_body_composition | 1.62536873 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.55614615 |
| 28 | MP0005025_abnormal_response_to | 1.55195464 |
| 29 | MP0005166_decreased_susceptibility_to | 1.54207920 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.53998498 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.53094185 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.51566158 |
| 33 | MP0003075_altered_response_to | 1.50508731 |
| 34 | MP0002254_reproductive_system_inflammat | 1.47965747 |
| 35 | MP0008260_abnormal_autophagy | 1.46514671 |
| 36 | MP0001764_abnormal_homeostasis | 1.42584118 |
| 37 | MP0001853_heart_inflammation | 1.41034370 |
| 38 | MP0004957_abnormal_blastocyst_morpholog | 1.40884796 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.39737903 |
| 40 | MP0003724_increased_susceptibility_to | 1.38469604 |
| 41 | MP0005165_increased_susceptibility_to | 1.37996537 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.36789012 |
| 43 | MP0001790_abnormal_immune_system | 1.36583090 |
| 44 | MP0005387_immune_system_phenotype | 1.36583090 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.34087024 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.32984789 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.32090781 |
| 48 | MP0001800_abnormal_humoral_immune | 1.31862616 |
| 49 | MP0005671_abnormal_response_to | 1.31616246 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.30297857 |
| 51 | MP0003866_abnormal_defecation | 1.29217477 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.27996644 |
| 53 | MP0008469_abnormal_protein_level | 1.27957639 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.26933815 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.25816952 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.24982573 |
| 57 | MP0002419_abnormal_innate_immunity | 1.24933767 |
| 58 | MP0002405_respiratory_system_inflammati | 1.24172114 |
| 59 | MP0006054_spinal_hemorrhage | 1.23628773 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.20961166 |
| 61 | MP0003195_calcinosis | 1.20800027 |
| 62 | MP0002136_abnormal_kidney_physiology | 1.19411784 |
| 63 | MP0000609_abnormal_liver_physiology | 1.18652218 |
| 64 | MP0002132_abnormal_respiratory_system | 1.18542326 |
| 65 | MP0002723_abnormal_immune_serum | 1.18535317 |
| 66 | MP0006082_CNS_inflammation | 1.18478354 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.15277370 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.14819540 |
| 69 | MP0001663_abnormal_digestive_system | 1.14661987 |
| 70 | MP0001819_abnormal_immune_cell | 1.13544063 |
| 71 | MP0003878_abnormal_ear_physiology | 1.13132775 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.13132775 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.12670529 |
| 74 | MP0002933_joint_inflammation | 1.09960397 |
| 75 | MP0009764_decreased_sensitivity_to | 1.07935811 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.07821954 |
| 77 | MP0000678_abnormal_parathyroid_gland | 1.07312381 |
| 78 | MP0004947_skin_inflammation | 1.06143909 |
| 79 | MP0005310_abnormal_salivary_gland | 1.05601946 |
| 80 | MP0003718_maternal_effect | 1.05010040 |
| 81 | MP0001765_abnormal_ion_homeostasis | 1.02611910 |
| 82 | MP0005164_abnormal_response_to | 1.01454982 |
| 83 | MP0004510_myositis | 1.00962385 |
| 84 | MP0000477_abnormal_intestine_morphology | 1.00899085 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.00548827 |
| 86 | MP0000858_altered_metastatic_potential | 1.00275350 |
| 87 | MP0005083_abnormal_biliary_tract | 0.99597993 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.96152352 |
| 89 | MP0001756_abnormal_urination | 0.96012791 |
| 90 | MP0000716_abnormal_immune_system | 0.95630902 |
| 91 | MP0000689_abnormal_spleen_morphology | 0.95425558 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.94053060 |
| 93 | MP0002006_tumorigenesis | 0.94046370 |
| 94 | MP0002396_abnormal_hematopoietic_system | 0.93493695 |
| 95 | MP0002398_abnormal_bone_marrow | 0.93182581 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.93108683 |
| 97 | MP0002722_abnormal_immune_system | 0.92992206 |
| 98 | MP0002429_abnormal_blood_cell | 0.90783415 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.90781723 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.89919731 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.86421350 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86345124 |
| 103 | MP0000598_abnormal_liver_morphology | 0.86308660 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.85922127 |
| 105 | MP0004043_abnormal_pH_regulation | 0.83347008 |
| 106 | MP0003077_abnormal_cell_cycle | 0.82719339 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.82289733 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.81125717 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.81125717 |
| 110 | MP0009763_increased_sensitivity_to | 0.80604763 |
| 111 | MP0005390_skeleton_phenotype | 0.80267145 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.79589768 |
| 113 | MP0002796_impaired_skin_barrier | 0.79068901 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.78359559 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.78202279 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.77983157 |
| 117 | MP0005023_abnormal_wound_healing | 0.77752263 |
| 118 | MP0002019_abnormal_tumor_incidence | 0.77682648 |
| 119 | MP0003448_altered_tumor_morphology | 0.77366789 |
| 120 | MP0008004_abnormal_stomach_pH | 0.76765538 |
| 121 | MP0000343_altered_response_to | 0.76454102 |
| 122 | MP0008873_increased_physiological_sensi | 0.74277072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.41761696 |
| 2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.35673188 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.33308078 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.33308078 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 6.02755282 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.02755282 |
| 7 | Abnormal ciliary motility (HP:0012262) | 5.95776963 |
| 8 | Rhinitis (HP:0012384) | 5.90130709 |
| 9 | Chronic bronchitis (HP:0004469) | 4.97878461 |
| 10 | Bronchiectasis (HP:0002110) | 4.79645530 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 4.77241313 |
| 12 | Recurrent sinusitis (HP:0011108) | 3.54413495 |
| 13 | Bronchitis (HP:0012387) | 3.39926650 |
| 14 | Increased IgM level (HP:0003496) | 3.23205547 |
| 15 | Chronic sinusitis (HP:0011109) | 3.18147620 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.17248219 |
| 17 | Recurrent otitis media (HP:0000403) | 3.10887807 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.04244713 |
| 19 | Pustule (HP:0200039) | 3.00228489 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.97724435 |
| 21 | Generalized aminoaciduria (HP:0002909) | 2.86713721 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.79815925 |
| 23 | Male infertility (HP:0003251) | 2.79749696 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.79728054 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 2.77125297 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 2.76061102 |
| 27 | Hyperglycinuria (HP:0003108) | 2.70588283 |
| 28 | Reticulocytopenia (HP:0001896) | 2.66550726 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63633544 |
| 30 | Glucose intolerance (HP:0000833) | 2.62846893 |
| 31 | Chronic otitis media (HP:0000389) | 2.58597333 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.58549486 |
| 33 | Infertility (HP:0000789) | 2.55390056 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53025166 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 2.53025166 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51757035 |
| 37 | Nausea (HP:0002018) | 2.51561643 |
| 38 | Proximal tubulopathy (HP:0000114) | 2.49279094 |
| 39 | Hyperammonemia (HP:0001987) | 2.47057456 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.42682253 |
| 41 | Ileus (HP:0002595) | 2.41237276 |
| 42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.40453495 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.38626224 |
| 44 | Myositis (HP:0100614) | 2.38482111 |
| 45 | Hepatic necrosis (HP:0002605) | 2.36502018 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.36272886 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.35773004 |
| 48 | Abnormal number of erythroid precursors (HP:0012131) | 2.33187915 |
| 49 | Glycosuria (HP:0003076) | 2.33016478 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.33016478 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31570689 |
| 52 | Petechiae (HP:0000967) | 2.30105516 |
| 53 | Thrombocytosis (HP:0001894) | 2.28763922 |
| 54 | Hypobetalipoproteinemia (HP:0003563) | 2.28539883 |
| 55 | Obstructive lung disease (HP:0006536) | 2.28034673 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28034673 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.27682243 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26817453 |
| 59 | Gout (HP:0001997) | 2.25176227 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25087873 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.24636247 |
| 62 | IgM deficiency (HP:0002850) | 2.21253067 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.21081918 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.21081918 |
| 65 | Atelectasis (HP:0100750) | 2.20996788 |
| 66 | Lethargy (HP:0001254) | 2.20185174 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20044168 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20044168 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20044168 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19753937 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17900505 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.17900505 |
| 73 | Stomatitis (HP:0010280) | 2.16231698 |
| 74 | Abnormal tarsal ossification (HP:0008369) | 2.11661827 |
| 75 | Fat malabsorption (HP:0002630) | 2.09961118 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09915774 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.09479656 |
| 78 | Increased serum ferritin (HP:0003281) | 2.08849116 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08607491 |
| 80 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08607491 |
| 81 | Abnormal hemoglobin (HP:0011902) | 2.06587217 |
| 82 | Combined immunodeficiency (HP:0005387) | 2.06191151 |
| 83 | Granulocytopenia (HP:0001913) | 2.05969874 |
| 84 | Malnutrition (HP:0004395) | 2.05701404 |
| 85 | Xanthomatosis (HP:0000991) | 2.05690932 |
| 86 | Trismus (HP:0000211) | 2.05676345 |
| 87 | Hyperactive renin-angiotensin system (HP:0000841) | 2.05271938 |
| 88 | Purpura (HP:0000979) | 2.04619491 |
| 89 | Recurrent fungal infections (HP:0002841) | 2.03932985 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.03808932 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03596234 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.03287971 |
| 93 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01723275 |
| 94 | Macrocytic anemia (HP:0001972) | 1.98976389 |
| 95 | Lip pit (HP:0100267) | 1.98854284 |
| 96 | Oral leukoplakia (HP:0002745) | 1.97748643 |
| 97 | Vasculitis (HP:0002633) | 1.96582343 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 1.95684825 |
| 99 | Recurrent skin infections (HP:0001581) | 1.94808489 |
| 100 | Hyperglycinemia (HP:0002154) | 1.94667731 |
| 101 | Meningitis (HP:0001287) | 1.94363515 |
| 102 | Alkalosis (HP:0001948) | 1.93074608 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 1.92347793 |
| 104 | Agammaglobulinemia (HP:0004432) | 1.91821546 |
| 105 | Dysostosis multiplex (HP:0000943) | 1.88278759 |
| 106 | Severe combined immunodeficiency (HP:0004430) | 1.87566434 |
| 107 | Cheilitis (HP:0100825) | 1.86210761 |
| 108 | Prolonged partial thromboplastin time (HP:0003645) | 1.85778308 |
| 109 | Hepatocellular necrosis (HP:0001404) | 1.85712744 |
| 110 | Hypertensive crisis (HP:0100735) | 1.85028402 |
| 111 | Abnormality of T cell number (HP:0011839) | 1.84853814 |
| 112 | Chronic diarrhea (HP:0002028) | 1.84012859 |
| 113 | Recurrent bronchitis (HP:0002837) | 1.83781409 |
| 114 | Vascular calcification (HP:0004934) | 1.83543127 |
| 115 | Hyperuricemia (HP:0002149) | 1.83435840 |
| 116 | Increased purine levels (HP:0004368) | 1.83435840 |
| 117 | Increased muscle lipid content (HP:0009058) | 1.81789931 |
| 118 | Abnormal glucose tolerance (HP:0001952) | 1.81680460 |
| 119 | Abnormality of chloride homeostasis (HP:0011422) | 1.81554495 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81232434 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81232434 |
| 122 | Esophageal varix (HP:0002040) | 1.81125779 |
| 123 | Eosinophilia (HP:0001880) | 1.80187807 |
| 124 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.78348315 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.76549917 |
| 126 | Hyperbilirubinemia (HP:0002904) | 1.76202620 |
| 127 | Mediastinal lymphadenopathy (HP:0100721) | 1.75184509 |
| 128 | Type I transferrin isoform profile (HP:0003642) | 1.75090756 |
| 129 | Hyperphosphaturia (HP:0003109) | 1.74652185 |
| 130 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.73974043 |
| 131 | 11 pairs of ribs (HP:0000878) | 1.73789211 |
| 132 | Abnormality of T cells (HP:0002843) | 1.73779156 |
| 133 | Rough bone trabeculation (HP:0100670) | 1.72995056 |
| 134 | Urticaria (HP:0001025) | 1.72701778 |
| 135 | Aplastic anemia (HP:0001915) | 1.72439491 |
| 136 | Nasal polyposis (HP:0100582) | 1.71413811 |
| 137 | Autoimmune hemolytic anemia (HP:0001890) | 1.70904677 |
| 138 | Nonimmune hydrops fetalis (HP:0001790) | 1.70670974 |
| 139 | Metabolic acidosis (HP:0001942) | 1.69493043 |
| 140 | Pancreatitis (HP:0001733) | 1.69140284 |
| 141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.68128879 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.68071417 |
| 143 | Inflammation of the large intestine (HP:0002037) | 1.67878634 |
| 144 | Steatorrhea (HP:0002570) | 1.67566129 |
| 145 | Lipid accumulation in hepatocytes (HP:0006561) | 1.66965721 |
| 146 | Joint hemorrhage (HP:0005261) | 1.66899978 |
| 147 | Interstitial pulmonary disease (HP:0006530) | 1.66858467 |
| 148 | Orchitis (HP:0100796) | 1.66451697 |
| 149 | Gastrointestinal stroma tumor (HP:0100723) | 1.64082267 |
| 150 | Axonal loss (HP:0003447) | 1.62197665 |
| 151 | Skin rash (HP:0000988) | 1.61417006 |
| 152 | Loss of speech (HP:0002371) | 1.60440342 |
| 153 | Pulmonary infiltrates (HP:0002113) | 1.57633490 |
| 154 | Hepatosplenomegaly (HP:0001433) | 1.57079680 |
| 155 | Seborrheic dermatitis (HP:0001051) | 1.56536719 |
| 156 | Vertebral compression fractures (HP:0002953) | 1.55745388 |
| 157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.53319248 |
| 158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.53319248 |
| 159 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.53319248 |
| 160 | Recurrent viral infections (HP:0004429) | 1.51904333 |
| 161 | Renal salt wasting (HP:0000127) | 1.51494403 |
| 162 | Amyloidosis (HP:0011034) | 1.51391237 |
| 163 | Hypochromic anemia (HP:0001931) | 1.49548608 |
| 164 | Gastrointestinal infarctions (HP:0005244) | 1.49408558 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.48944872 |
| 166 | Mucopolysacchariduria (HP:0008155) | 1.48944872 |
| 167 | Increased intramyocellular lipid droplets (HP:0012240) | 1.47829915 |
| 168 | Severe visual impairment (HP:0001141) | 1.47282911 |
| 169 | Joint swelling (HP:0001386) | 1.44176380 |
| 170 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.44168796 |
| 171 | Villous atrophy (HP:0011473) | 1.44168796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.05423750 |
| 2 | ERN1 | 2.75357952 |
| 3 | MST4 | 2.59173206 |
| 4 | EIF2AK1 | 2.41928867 |
| 5 | BCKDK | 2.29400066 |
| 6 | TESK1 | 2.25611221 |
| 7 | MAP4K1 | 2.24923899 |
| 8 | BUB1 | 2.23878699 |
| 9 | IRAK3 | 2.23693463 |
| 10 | PBK | 1.99440110 |
| 11 | MAP3K14 | 1.93073610 |
| 12 | KDR | 1.92066804 |
| 13 | MAP2K2 | 1.91376237 |
| 14 | RIPK4 | 1.90684675 |
| 15 | EPHA2 | 1.90022362 |
| 16 | PIM2 | 1.86337065 |
| 17 | BLK | 1.80975785 |
| 18 | TESK2 | 1.77904945 |
| 19 | MAP3K3 | 1.71889393 |
| 20 | TBK1 | 1.69424790 |
| 21 | SMG1 | 1.68717535 |
| 22 | MAP3K12 | 1.67786970 |
| 23 | VRK2 | 1.51613592 |
| 24 | NUAK1 | 1.51586984 |
| 25 | MST1R | 1.49032097 |
| 26 | TAOK2 | 1.48955820 |
| 27 | EIF2AK3 | 1.47902654 |
| 28 | TYK2 | 1.46098310 |
| 29 | TEC | 1.42551794 |
| 30 | IRAK4 | 1.39805114 |
| 31 | MAP3K11 | 1.36780709 |
| 32 | STK10 | 1.36592879 |
| 33 | WEE1 | 1.34863055 |
| 34 | STK24 | 1.32845128 |
| 35 | RPS6KA4 | 1.29307880 |
| 36 | IKBKE | 1.29267304 |
| 37 | ARAF | 1.28919311 |
| 38 | NLK | 1.28608124 |
| 39 | RPS6KB2 | 1.25328337 |
| 40 | ZAP70 | 1.24740830 |
| 41 | TTK | 1.21551585 |
| 42 | NEK2 | 1.20259173 |
| 43 | TRIB3 | 1.19578662 |
| 44 | STK38L | 1.19540239 |
| 45 | LRRK2 | 1.18832883 |
| 46 | DYRK3 | 1.17416900 |
| 47 | STK16 | 1.16803309 |
| 48 | EPHB1 | 1.12861985 |
| 49 | BMPR2 | 1.12128081 |
| 50 | IKBKB | 1.09916989 |
| 51 | BTK | 1.06756703 |
| 52 | MAP2K3 | 1.06554429 |
| 53 | PAK4 | 1.05811401 |
| 54 | NME1 | 1.05789783 |
| 55 | GRK6 | 1.04921909 |
| 56 | MAP3K10 | 1.04805878 |
| 57 | PRPF4B | 1.02662607 |
| 58 | PLK4 | 1.02100498 |
| 59 | FRK | 0.97298073 |
| 60 | PRKG2 | 0.96311540 |
| 61 | PIM1 | 0.95252991 |
| 62 | AURKB | 0.93699689 |
| 63 | BRSK2 | 0.92567478 |
| 64 | MAP3K8 | 0.90804633 |
| 65 | TAOK1 | 0.88239321 |
| 66 | MAP3K1 | 0.86987722 |
| 67 | VRK1 | 0.86536944 |
| 68 | MAP2K6 | 0.86485834 |
| 69 | LIMK1 | 0.85655974 |
| 70 | ABL2 | 0.85654387 |
| 71 | PDK2 | 0.85212836 |
| 72 | TLK1 | 0.84670792 |
| 73 | TXK | 0.82882280 |
| 74 | FGFR4 | 0.81100795 |
| 75 | RIPK1 | 0.80946412 |
| 76 | PIK3CG | 0.80682539 |
| 77 | STK4 | 0.79160696 |
| 78 | JAK3 | 0.78658956 |
| 79 | TAOK3 | 0.75057219 |
| 80 | MAP3K13 | 0.74715590 |
| 81 | MAPKAPK3 | 0.74660011 |
| 82 | CDK19 | 0.74247439 |
| 83 | ZAK | 0.73410707 |
| 84 | CSK | 0.72659657 |
| 85 | MAP3K2 | 0.72344646 |
| 86 | SCYL2 | 0.70392086 |
| 87 | WNK4 | 0.69940632 |
| 88 | CHUK | 0.69932894 |
| 89 | SIK3 | 0.67400782 |
| 90 | LCK | 0.67178043 |
| 91 | PRKCI | 0.65153398 |
| 92 | LMTK2 | 0.64633868 |
| 93 | PASK | 0.64297803 |
| 94 | PTK2 | 0.63645860 |
| 95 | PLK1 | 0.63323886 |
| 96 | TNK2 | 0.62113605 |
| 97 | PDPK1 | 0.61993100 |
| 98 | DYRK1B | 0.61465036 |
| 99 | PRKCQ | 0.61131972 |
| 100 | PDK3 | 0.60199344 |
| 101 | PDK4 | 0.60199344 |
| 102 | CLK1 | 0.59772474 |
| 103 | SIK1 | 0.58973942 |
| 104 | CDK4 | 0.58509711 |
| 105 | LYN | 0.57374106 |
| 106 | MYLK | 0.56920635 |
| 107 | CDK7 | 0.56636219 |
| 108 | PTK6 | 0.55764696 |
| 109 | MAPK15 | 0.55684741 |
| 110 | TGFBR2 | 0.54448438 |
| 111 | PIK3CA | 0.54436691 |
| 112 | JAK1 | 0.51927089 |
| 113 | ITK | 0.51583800 |
| 114 | FES | 0.50895891 |
| 115 | DAPK1 | 0.50361417 |
| 116 | KIT | 0.49881460 |
| 117 | HIPK2 | 0.49656620 |
| 118 | NEK9 | 0.49464249 |
| 119 | SYK | 0.48904645 |
| 120 | MAPK11 | 0.48352967 |
| 121 | GRK7 | 0.47979419 |
| 122 | PAK1 | 0.45035843 |
| 123 | PDK1 | 0.45022228 |
| 124 | ACVR1B | 0.44626405 |
| 125 | MOS | 0.41496607 |
| 126 | HCK | 0.41071771 |
| 127 | MAPKAPK2 | 0.40610873 |
| 128 | MATK | 0.40102464 |
| 129 | PRKCD | 0.39907377 |
| 130 | CSNK2A1 | 0.39724812 |
| 131 | GRK1 | 0.39109314 |
| 132 | ILK | 0.37223157 |
| 133 | MAPK12 | 0.36317640 |
| 134 | FLT3 | 0.36137309 |
| 135 | CSF1R | 0.36108976 |
| 136 | MARK3 | 0.36016709 |
| 137 | MAP3K5 | 0.30682613 |
| 138 | PTK2B | 0.30272118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.11295016 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92560727 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.78232945 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.64661044 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46501074 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.44833101 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.24466023 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.23841032 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.17726768 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.07252787 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00652911 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.96539344 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.83568971 |
| 14 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.81504463 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78776625 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70967622 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67624221 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66072451 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61374767 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60299108 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53229017 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.52428523 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50034096 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.47128842 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.46600681 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45952539 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44573579 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42541301 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40989330 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.37614351 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37527936 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37281416 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36306348 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36212450 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34823533 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34651910 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.32807733 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32147614 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31735390 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26424633 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23678241 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21557427 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.21274814 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.21123248 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.16678328 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16045256 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14200660 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.12758892 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12749594 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11540894 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.08891464 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08395422 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08022411 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.07213381 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07163011 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06411013 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06273363 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06027349 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03092859 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01534686 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01064996 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99723152 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99612342 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99294122 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98403877 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98026508 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97438432 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96931579 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95909247 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94781519 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93765725 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93564864 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93216676 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92682091 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91278752 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91073999 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.90837928 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90566683 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.90464356 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90158553 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88959956 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.87295523 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86918673 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84856161 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84327295 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83588643 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81959350 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81930797 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.81445074 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80784059 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80288526 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.79623744 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79175084 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.79067354 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78804019 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.78763863 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77196568 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76962855 |
| 99 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75802762 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75348313 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75209153 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.74250053 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73072469 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71999155 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71987733 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.70809634 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70111922 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68724956 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68260546 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66343401 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64587609 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64062967 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.63240944 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62767390 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.59732966 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59606739 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59507447 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56171337 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55500548 |
| 120 | Spliceosome_Homo sapiens_hsa03040 | 0.55206738 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55120848 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55061395 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54762316 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53973163 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.53803874 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53233567 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52046358 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52013414 |
| 129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51771062 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.51365745 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50908158 |
| 132 | RNA transport_Homo sapiens_hsa03013 | 0.50528514 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49931286 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49878501 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49622537 |
| 136 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49340872 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48717209 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47877091 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47651165 |
| 140 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47267435 |
| 141 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46766214 |
| 142 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46734519 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.46650859 |
| 144 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41869302 |

